DrugPatentWatch Database Preview
Neos Theraps Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for NEOS THERAPS INC, and what generic alternatives to NEOS THERAPS INC drugs are available?
NEOS THERAPS INC has two approved drugs.
There are six US patents protecting NEOS THERAPS INC drugs.
There are two patent family members on NEOS THERAPS INC drugs in two countries.
Drugs and US Patents for Neos Theraps Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-002 | Jun 19, 2017 | RX | Yes | No | Start Trial | Start Trial | |||||
Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-001 | Jun 19, 2017 | RX | Yes | No | 9,089,496 | Start Trial | Y | Start Trial | |||
Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-001 | Jun 19, 2017 | RX | Yes | No | 8,840,924 | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Neos Theraps Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2726066 | Start Trial |
World Intellectual Property Organization (WIPO) | 2013003622 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.